$196 Million is the total value of DCF Advisers, LLC's 86 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 21.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GLD | Sell | SPDR GOLD TR | $11,247,000 | -4.0% | 63,500 | -9.3% | 5.75% | -12.3% |
| XNCR | Sell | XENCOR INC | $7,312,000 | +18.6% | 188,500 | -1.0% | 3.74% | +8.4% |
| Sell | INVESCO QQQ TRput | $7,224,000 | -41.6% | 26,000 | -48.0% | 3.69% | -46.7% | |
| MU | Sell | MICRON TECHNOLOGY INC | $7,208,000 | -11.2% | 153,500 | -2.5% | 3.69% | -18.8% |
| AMD | Sell | ADVANCED MICRO DEVICES INC | $4,509,000 | +14.3% | 55,000 | -26.7% | 2.31% | +4.4% |
| AMGN | Sell | AMGEN INC | $2,859,000 | +3.2% | 11,250 | -4.3% | 1.46% | -5.7% |
| SGEN | Sell | SEATTLE GENETICS INC | $2,544,000 | +6.9% | 13,000 | -7.1% | 1.30% | -2.3% |
| XLNX | Sell | XILINX INC | $2,059,000 | -7.0% | 19,750 | -12.2% | 1.05% | -15.0% |
| LOW | Sell | LOWES COS INC | $1,244,000 | -26.3% | 7,500 | -40.0% | 0.64% | -32.7% |
| Sell | ORACLE CORPcall | $896,000 | -28.0% | 15,000 | -33.3% | 0.46% | -34.2% | |
| BRKB | Sell | BERKSHIRE HATHAWAY INC DELcl b new | $852,000 | -58.5% | 4,000 | -65.2% | 0.44% | -62.1% |
| APTV | Sell | APTIV PLC | $688,000 | -11.7% | 7,500 | -25.0% | 0.35% | -19.3% |
| NLOK | Sell | NORTONLIFELOCK INC | $625,000 | -21.2% | 30,000 | -25.0% | 0.32% | -27.9% |
| Sell | MICRON TECHNOLOGY INCcall | $540,000 | -58.1% | 11,500 | -54.0% | 0.28% | -61.7% | |
| NKTR | Sell | NEKTAR THERAPEUTICS | $528,000 | -47.0% | 31,800 | -26.0% | 0.27% | -51.5% |
| Sell | VANECK VECTORS ETF TRcall | $490,000 | -40.6% | 12,500 | -44.4% | 0.25% | -45.7% | |
| MTNB | Sell | MATINAS BIOPHARMA HLDGS INC | $423,000 | -3.0% | 551,795 | -2.1% | 0.22% | -11.5% |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $382,000 | -39.5% | 40,400 | -42.6% | 0.20% | -44.8% |
| APTX | Sell | APTINYX INC | $310,000 | -30.3% | 91,800 | -14.0% | 0.16% | -36.1% |
| QCOM | Sell | QUALCOMM INC | $294,000 | -35.5% | 2,500 | -50.0% | 0.15% | -41.2% |
| IDRA | Sell | IDERA PHARMACEUTICALS INC | $225,000 | +17.2% | 105,000 | -2.0% | 0.12% | +7.5% |
| KIRK | Sell | KIRKLANDS INC | $148,000 | -66.8% | 18,000 | -89.1% | 0.08% | -69.6% |
| Exit | KOHLS CORcall | $0 | – | -10,000 | -100.0% | -0.12% | – | |
| Exit | INTRA CELLULAR THERAPIES INCcall | $0 | – | -10,000 | -100.0% | -0.14% | – | |
| Exit | CISCO SYS INCcall | $0 | – | -10,000 | -100.0% | -0.26% | – | |
| Exit | ORACLE CORPput | $0 | – | -10,000 | -100.0% | -0.31% | – | |
| Exit | CITIGROUP INCput | $0 | – | -15,000 | -100.0% | -0.43% | – | |
| Exit | INCYTE CORPcall | $0 | – | -10,000 | -100.0% | -0.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 16 | Q3 2023 | 10.2% |
| MICRON TECHNOLOGY INC | 16 | Q3 2023 | 6.7% |
| ALPHABET INC | 16 | Q3 2023 | 5.8% |
| ABBVIE INC | 16 | Q3 2023 | 7.9% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 5.5% |
| ARGENX SE | 16 | Q3 2023 | 6.4% |
| SPDR GOLD TRUST | 16 | Q3 2023 | 6.6% |
| XENCOR INC | 16 | Q3 2023 | 4.1% |
| BK OF AMERICA CORP | 16 | Q3 2023 | 5.4% |
| ORACLE CORP | 16 | Q3 2023 | 3.2% |
View DCF Advisers, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-15 |
View DCF Advisers, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.